Evidence map›Paper›PMID 27664068›Full record

ArticleJournal of neuroinflammation2016

CXCL12-induced neurotoxicity critically depends on NMDA receptor-gated and L-type Ca

Ana B Sanchez, Kathryn E Medders, Ricky Maung, Paloma Sánchez-Pavón, Daniel Ojeda-Juárez, Marcus Kaul

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ana B SanchezInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA.
Kathryn E MeddersInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA.
Ricky MaungInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA.
Paloma Sánchez-PavónInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA.
Daniel Ojeda-JuárezInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA.
Marcus KaulInfectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, Bldg. 10, La Jolla, CA, 92037, USA. mkaul@SBPdiscovery.org.ORCID http://orcid.org/0000-0003-3202-670X
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of San Diego · US

Funding

Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
Neuroprotection by IFN-beta in AIDSR01MH087332 · NIMH · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI KAUL, MARCUS · 2010 to 2019
$5.2M
Lipocalin-2 in HIV-Associated Neuronal InjuryR01MH104131 · NIMH · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI KAUL, MARCUS · 2015 to 2019
$2.2M
Cysteinyl Leukotrienes in HIV Brain InjuryR01MH105330 · NIMH · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI KAUL, MARCUS · 2015 to 2019
$2.0M
Chemokine Receptor Signaling in HIV NeuropathologyR01NS050621 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUL, MARCUS · 2004 to 2007
$1.4M
NIDA NIH HHS P50 DA026306NIMH NIH HHS R01 MH087332NIMH NIH HHS R01 MH104131NIMH NIH HHS R01 MH105330NINDS NIH HHS R01 NS050621
6 · The paper itself

Abstract

backgroundThe chemokine receptor CXCR4 (CD184) and its natural ligand CXCL12 contribute to many physiological processes, including decisions about cell death and survival in the central nervous system. In addition, CXCR4 is a co-receptor for human immunodeficiency virus (HIV)-1 and mediates the neurotoxicity of the viral envelope protein gp120. However, we previously observed that CXCL12 also causes toxicity in cerebrocortical neurons but the cellular mechanism remained incompletely defined.

methodsPrimary neuronal-glial cerebrocortical cell cultures from rat were exposed to a neurotoxicity-inducing CXCL12 concentration for different times and the activity of the stress-associated mitogen-activated protein kinase p38 (p38 MAPK) was assessed using an in vitro kinase assay. Neurotoxicity of CXCL12 and cellular localization of p38 MAPK was analyzed by immunofluorescence microscopy. Pharmacological inhibition of NMDA-type glutamate receptor-gated ion channels (NMDAR) of L-type Ca

resultsHere, we show that a neurotoxic amount of CXCL12 triggers a significant increase of endogenous p38 MAPK activity in cerebrocortical cells. Immunofluorescence and Western blotting experiments with mixed neuronal-glial and neuron-depleted glial cerebrocortical cells revealed that the majority of active/phosphorylated p38 MAPK was located in neurons. Blockade of NMDAR-gated ion channels or L-type Ca

conclusionsOur findings link CXCL12-induced neuronal death to the regulation of NMDAR-gated ion channels and L-type Ca

Indexed as

Calcium channelCell deathCXCL12CXCR4Immunofluorescence microscopyInhibitorsKinase activityNeurotoxicityp38 MAPK

Identifiers

PMID27664068
PMCPMC5035480
OpenAlexW2521220667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.